Related Experiment Video

Updated: Sep 28, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.4K

Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus

James P d'Etienne1, Naomi Alanis1, Eric Chou2

  • 1Department of Emergency Medicine, JPS Health Network, 1500 S. Main St., Fort Worth, TX 76104, United States of America.

The American Journal of Emergency Medicine
|April 2, 2022
PubMed

Insights

A simplified comorbidity evaluation accurately predicts COVID-19 severity and outcomes, performing comparably to the Charlson Comorbidity Index (CCI) across different pandemic waves.

Area of Science:

  • Epidemiology
  • Clinical Medicine
  • Public Health

Background:

  • Assessing patient comorbidities is crucial for predicting COVID-19 severity.
  • The Charlson Comorbidity Index (CCI) is a standard but complex tool.
  • Simplified comorbidity evaluations may offer a more accessible alternative.

Purpose of the Study:

  • To compare the predictive accuracy of a simplified comorbidity evaluation against the CCI for COVID-19 severity.
  • To determine if risk prediction efficacy varied across different COVID-19 pandemic waves.
  • To validate the simplified evaluation's association with clinical outcomes.

Main Methods:

  • Retrospective analysis of 22,248 patients undergoing SARS-CoV-2 PCR testing in 2020.
  • Patients categorized into three groups based on US COVID-19 outbreak waves.
  • Multivariate logistic regression used to assess simplified comorbidity evaluation as a predictor of clinical outcomes.

Main Results:

  • 32% (7023) of patients tested positive for COVID-19.
  • Patients with >3 chronic conditions showed worse outcomes (hospitalization, ICU admission, ventilation, mortality) across all waves.
  • Simplified comorbidity evaluation demonstrated significant association with COVID-19 clinical outcomes.

Conclusions:

  • A simplified comorbidity evaluation is a validated predictor of COVID-19 clinical outcomes.
  • This simplified method demonstrated comparable performance to the CCI in predicting in-hospital mortality.
  • The simplified evaluation remains effective across different COVID-19 outbreak periods.
Abstract

Keywords:
COVID-19Clinical outcomesComorbidityPandemic outbreaks

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-1908:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
649
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
488
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60